Skip to content

Choice of antibiotics for the treatment of infection in newborn babies

Comparision of Levofloxacin and Amikacin versus Piperacillin-tazobactam and Amikacin for the Treatment of Neonatal Sepsis: A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056272
Enrollment
180
Registered
2023-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P369- Bacterial sepsis of newborn, unspecified

Interventions

Intervention1: Injection Levofloxacin and Amikacin: Injection Levofloxacin and Amikacin will be administered to newborns with suspected or confirmed sepsis using standard doses adjusted to gestational

Sponsors

Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The diagnosis of neonatal sepsis will be based on the presence of the following criteria, as defined by the European Medicines Agency (2010). Per EMA criteria there should be at least 2 clinical and 2 laboratory signs for making a diagnosis of suspected or confirmed neonatal sepsis. These criteria are as follows: Clinical symptoms (2 or more) 1. If core body temperature >38.5°C or 2. Cardiovascular instability: Bradycardia, (heart rate 180/min), Rhythm instability, Reduced urine output ( 3 seconds 3. Respiratory instability: Apnea (cessation of breathing for >20 seconds), Tachypnea (respiratory rate >60/min, Increased oxygen requirement >10%, Requirement of ventilatory support 4. Petechial rash or sclerema. 5. Feed intolerance or poor sucking or abdominal distension. 6. Central nervous system: Irritability, Lethargy, Hypotonia, Seizure 7. Cellulitis or skin ulceration. 8. Non-specific: irritability or lethargy or hypotonia Laboratory signs (2 or more) 1. White blood cells (WBC) count 20,000/cubic mm. 2. Platelet count 3. Immature to total neutrophil ratio >0.2 4. C-reactive protein >10 mg/L 5. Glucose intolerance confirmed at least 2 times: hyperglycemia (blood glucose >180 mg/dL or 10mmol/L) or hypoglycemia (blood glucose 6. Metabolic acidosis: Base excess (BE) below -10 mEq/L or Serum lactate >2 mmol/L. 7. Chest X-ray suggestive of bronchopneumonia 8. Cerebrosinal fluid changes suggestive of septic meningitis.

Exclusion criteria

Exclusion criteria: 1. Newborns receiving prophylactic antibiotics 2. Surgical conditions and life threatening congenital malformations 3. Failure to obtain consent 4. Prior exposure of antibiotics

Design outcomes

Primary

MeasureTime frame
Treatment failure defined as a need for changing initial antibiotics regimen within 72 hours or earlier if treating physician considers it necessary in view of rapidly deteriorating clinical condition of newborn or patient not cured by 7 days after enrollment.Timepoint: 7 days

Secondary

MeasureTime frame
1. Mortality during hospitalization 2. Adverse effects of therapy 3. Duration of hospitalizationTimepoint: During hospitalization

Countries

India

Contacts

Public ContactAyush Yadav

Banaras Hindu University

ashokkumar_bhu@hotmail.com09415300370

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026